<html>

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=Generator content="Microsoft Word 15 (filtered)">
<base href="SBA%206/26/25%202R">
<title>S3486 2R</title>
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:"Albertus Extra Bold";
	panose-1:2 14 8 2 4 3 4 2 2 4;}
@font-face
	{font-family:Marlett;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
	{font-family:"Segoe UI";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:AlbertusExtraBold;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{mso-style-link:"Footer Char";
	margin:0in;
	margin-bottom:.0001pt;
	font-size:9.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.MsoDocumentMap, li.MsoDocumentMap, div.MsoDocumentMap
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	background:navy;
	font-size:12.0pt;
	font-family:"Tahoma",sans-serif;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{mso-style-link:"Balloon Text Char";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:9.0pt;
	font-family:"Segoe UI",sans-serif;
	letter-spacing:.2pt;}
span.11ptChar
	{mso-style-name:11ptChar;
	font-family:"Times New Roman",serif;}
span.BillHead
	{mso-style-name:BillHead;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;
	font-weight:bold;}
span.BillHeading2
	{mso-style-name:BillHeading2;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;
	font-weight:bold;}
span.BillHeadUnBold
	{mso-style-name:BillHeadUnBold;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;}
span.BillLanguage
	{mso-style-name:BillLanguage;
	font-family:"Times New Roman",serif;
	font-style:italic;}
p.bpuBill, li.bpuBill, div.bpuBill
	{mso-style-name:bpuBill;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:26.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuHeadSpon, li.bpuHeadSpon, div.bpuHeadSpon
	{mso-style-name:bpuHeadSpon;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
span.bpuHeadSponChar
	{mso-style-name:bpuHeadSponChar;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuIntro, li.bpuIntro, div.bpuIntro
	{mso-style-name:bpuIntro;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.bpuLegislature, li.bpuLegislature, div.bpuLegislature
	{mso-style-name:bpuLegislature;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:24.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuNormText, li.bpuNormText, div.bpuNormText
	{mso-style-name:bpuNormText;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.bpuReprint, li.bpuReprint, div.bpuReprint
	{mso-style-name:bpuReprint;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:22.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.bpuSponsor, li.bpuSponsor, div.bpuSponsor
	{mso-style-name:bpuSponsor;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuState, li.bpuState, div.bpuState
	{mso-style-name:bpuState;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:32.0pt;
	font-family:"Arial",sans-serif;
	font-weight:bold;}
span.charMarlett
	{mso-style-name:charMarlett;
	font-family:Marlett;}
p.ElevenPt, li.ElevenPt, div.ElevenPt
	{mso-style-name:ElevenPt;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPage, li.FronterPage, div.FronterPage
	{mso-style-name:FronterPage;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPage12pt, li.FronterPage12pt, div.FronterPage12pt
	{mso-style-name:FronterPage12pt;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPageBillHeading, li.FronterPageBillHeading, div.FronterPageBillHeading
	{mso-style-name:FronterPageBillHeading;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;}
p.FronterPageTBox2, li.FronterPageTBox2, div.FronterPageTBox2
	{mso-style-name:FronterPageTBox2;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPageTextBox, li.FronterPageTextBox, div.FronterPageTextBox
	{mso-style-name:FronterPageTextBox;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.FronterSameAs, li.FronterSameAs, div.FronterSameAs
	{mso-style-name:FronterSameAs;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.HangingAnAct, li.HangingAnAct, div.HangingAnAct
	{mso-style-name:HangingAnAct;
	mso-style-link:"HangingAnAct Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.HangingAnActChar
	{mso-style-name:"HangingAnAct Char";
	mso-style-link:HangingAnAct;
	letter-spacing:.2pt;}
span.Para10pt
	{mso-style-name:Para10pt;
	font-family:"Times New Roman",serif;}
p.Pg2Footer, li.Pg2Footer, div.Pg2Footer
	{mso-style-name:Pg2Footer;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:8.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.StyleFronterPage11pt, li.StyleFronterPage11pt, div.StyleFronterPage11pt
	{mso-style-name:"Style FronterPage + 11 pt";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.StyleFronterPageLoweredby3pt, li.StyleFronterPageLoweredby3pt, div.StyleFronterPageLoweredby3pt
	{mso-style-name:"Style FronterPage + Lowered by  3 pt";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	position:relative;
	top:3.0pt;}
p.StyleFronterSameAsPatternSolid100White, li.StyleFronterSameAsPatternSolid100White, div.StyleFronterSameAsPatternSolid100White
	{mso-style-name:"Style FronterSameAs + Pattern\: Solid \(100%\) \(White\)";
	margin:0in;
	margin-bottom:.0001pt;
	background:white;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.Style1, li.Style1, div.Style1
	{mso-style-name:Style1;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
span.Whereas
	{mso-style-name:Whereas;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;
	font-weight:bold;}
span.Style10pt
	{mso-style-name:"Style 10 pt";
	font-family:"Times New Roman",serif;}
p.FronterPageNOCAPS, li.FronterPageNOCAPS, div.FronterPageNOCAPS
	{mso-style-name:FronterPageNOCAPS;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.bpuWpGraphic, li.bpuWpGraphic, div.bpuWpGraphic
	{mso-style-name:bpuWpGraphic;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.sponUdate, li.sponUdate, div.sponUdate
	{mso-style-name:sponUdate;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
span.fronterpagebillhead
	{mso-style-name:fronterpagebillhead;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;}
p.FPHangingAnAct, li.FPHangingAnAct, div.FPHangingAnAct
	{mso-style-name:FPHangingAnAct;
	mso-style-link:"FPHangingAnAct Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.4in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.FPHangingAnActChar
	{mso-style-name:"FPHangingAnAct Char";
	mso-style-link:FPHangingAnAct;
	letter-spacing:.2pt;}
span.LeftBrackt
	{mso-style-name:LeftBrackt;
	font-family:"Albertus Extra Bold",sans-serif;
	font-weight:bold;}
span.RightBrackt
	{mso-style-name:RightBrackt;
	font-family:"Albertus Extra Bold",sans-serif;
	font-weight:bold;}
span.BoldItal
	{mso-style-name:BoldItal;
	font-weight:bold;
	font-style:italic;}
p.HangingSup, li.HangingSup, div.HangingSup
	{mso-style-name:HangingSup;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.HangingTableBottom, li.HangingTableBottom, div.HangingTableBottom
	{mso-style-name:HangingTableBottom;
	margin-top:0in;
	margin-right:1.0in;
	margin-bottom:0in;
	margin-left:.8in;
	margin-bottom:.0001pt;
	text-indent:-.8in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.HangingTableTop, li.HangingTableTop, div.HangingTableTop
	{mso-style-name:HangingTableTop;
	margin-top:0in;
	margin-right:.5in;
	margin-bottom:0in;
	margin-left:.8in;
	margin-bottom:.0001pt;
	text-indent:-.8in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.BalloonTextChar
	{mso-style-name:"Balloon Text Char";
	mso-style-link:"Balloon Text";
	font-family:"Segoe UI",sans-serif;
	letter-spacing:.2pt;}
span.FooterChar
	{mso-style-name:"Footer Char";
	mso-style-link:Footer;
	font-weight:bold;}
.MsoChpDefault
	{font-size:10.0pt;}
 /* Page Definitions */
 @page WordSection1
	{size:8.5in 14.0in;
	margin:1.5in 1.0in 1.0in 1.0in;}
div.WordSection1
	{page:WordSection1;}
@page WordSection2
	{size:8.5in 14.0in;
	margin:1.0in 113.75pt 1.0in 113.75pt;}
div.WordSection2
	{page:WordSection2;}
@page WordSection3
	{size:8.5in 14.0in;
	margin:1.0in 1.75in 1.3in 2.0in;}
div.WordSection3
	{page:WordSection3;}
-->
</style>

</head>

<body lang=EN-US>

<div class=WordSection1>

<p class=bpuReprint>[Second Reprint]</p>

<p class=bpuBill>SENATE, No. 3486 </p>

<p class=bpuWpGraphic><b><span style='font-size:32.0pt;line-height:120%;
font-family:"Arial",sans-serif;letter-spacing:0pt'>STATE OF NEW JERSEY</span></b></p>

<p class=bpuLegislature>221st LEGISLATURE</p>

<p class=bpuWpGraphic>  </p>

<p class=bpuIntro>INTRODUCED JUNE 24, 2024</p>

<p class=bpuIntro>&nbsp;</p>

</div>

<span style='font-size:11.0pt;line-height:120%;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:auto'>
</span>

<div class=WordSection2>

<p class=bpuIntro>&nbsp;</p>

<p class=bpuSponsor>Sponsored by:</p>

<p class=bpuSponsor>Senator  VIN GOPAL</p>

<p class=bpuSponsor>District 11 (Monmouth)</p>

<p class=bpuSponsor>Senator  SHIRLEY K. TURNER</p>

<p class=bpuSponsor>District 15 (Hunterdon and Mercer)</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>SYNOPSIS</p>

<p class=MsoNormal><span style='letter-spacing:0pt'>      Concerns satellite
cannabis dispensaries, Cannabis Regulatory Commission membership, and
post-employment restrictions on State employees.</span></p>

<p class=bpuNormText>&nbsp;</p>

<p class=bpuSponsor>CURRENT VERSION OF TEXT </p>

<p class=bpuNormText>     As reported by the Senate Budget and Appropriations
Committee on June 26, 2025, with amendments.</p>

<p class=bpuNormText>   </p>

</div>

<span style='font-size:12.0pt;line-height:120%;font-family:"Times New Roman",serif;
letter-spacing:.2pt'><br clear=all style='page-break-before:always'>
</span>

<div class=WordSection3>

<p class=MsoNormal style='margin-left:.2in;text-indent:-.2in;line-height:150%'><b><span
style='line-height:150%;font-variant:small-caps'>An Act</span></b> concerning
satellite locations of medical cannabis dispensaries, <b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>2</span></sup></b><u><span
style='letter-spacing:0pt'>Cannabis Regulatory Commission membership, and
employment rights of State employees,</span></u><b><sup><span style='font-family:
"Albertus Extra Bold",sans-serif'>2</span></sup></b> and amending P.L.2009,
c.307 <b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>2</span></sup></b><u><span
style='letter-spacing:0pt'>, P.L.2019, c.153, and P.L.1981, c.142</span></u><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>2</span></sup></b>.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     <span class=BillHeading2>Be It
Enacted </span><span class=BillLanguage>by the Senate and General Assembly of
the State of New Jersey:</span></p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      1.   Section
7 of P.L.2009, c.307 (C.24:6I-7) is amended to read as follows:</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      7. 
a.  (1)  The commission shall accept applications from entities for permits to
operate as medical cannabis cultivators, medical cannabis manufacturers, and
medical cannabis dispensaries.  For the purposes of this section, the term
&quot;permit&quot; shall be deemed to include a conditional permit issued
pursuant to subsection d. of section 11 of P.L.2019, c.153 (C.24:6I-7.1) and
any permit issued to a microbusiness pursuant to subsection e. of section 11 of
P.L.2019, c.153 (C.24:6I-7.1).</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (2)
(a) For a period of 18 months after the effective date of P.L.2019, c.153
(C.24:6I-5.1 et al.):</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (i)  no
applicant may concurrently hold more than one permit issued by the commission
pursuant to this section, regardless of type; and</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (ii) there
shall be no more than 28 active medical cannabis cultivator permits, including
medical cannabis cultivator permits deemed to be held by alternative treatment
centers issued a permit prior to the effective date of P.L.2019, c.153
(C.24:6I-5.1 et al.) and medical cannabis cultivator permits deemed to be held
by alternative treatment centers issued a permit subsequent to the effective
date of P.L.2019, c.153 (C.24:6I-5.1 et al.) pursuant to an application
submitted prior to the effective date of P.L.2019, c.153 (C.24:6I-5.1 et al.);
provided that medical cannabis cultivator permits issued to microbusinesses
pursuant to subsection e. of section 11 of P.L.2019, c.153 (C.24:6I-7.1) shall
not count toward this limit.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (b) Commencing
18 months after the effective date of P.L.2019, c.153 (C.24:6I-5.1 et al.), a
permit holder shall be authorized to concurrently hold a medical cannabis
cultivator permit, a medical cannabis manufacturer permit, and a medical
cannabis dispensary permit, provided that no permit holder shall be authorized
to concurrently hold more than one permit of each type.  The permit holder may
submit an application for a permit of any type that the permit holder does not
currently hold prior to the expiration of the 18-month period described in
subparagraph (a) of this paragraph, provided that no additional permit shall be
awarded to the permit holder during the 18-month period. </span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (c)
(i) The provisions of subparagraph (a) of this paragraph shall not apply to any
alternative treatment center that was issued a permit prior to the effective
date of P.L.2019, c.153 (C.24:6I-5.1 et al.), to any alternative treatment
center that was issued a permit after the effective date of P.L.2019, c.153
(C.24:6I-5.1 et al.) pursuant to an application submitted prior to the
effective date of P.L.2019, c.153 (C.24:6I-5.1 et al.), to one of the four
alternative treatment centers issued a permit pursuant to an application
submitted after the effective date of P.L.2019, c.153 (C.24:6I-5.1 et al.)
pursuant to a request for applications published in the New Jersey Register
prior to the effective date of P.L.2019, c.153 (C.24:6I-5.1 et al.) that are
expressly exempt from the provisions of subsubparagraph (i) of subparagraph (a)
of this paragraph, or to one of the three alternative treatment centers issued
a permit pursuant to section 11 of P.L.2019, c.153 (C.24:6I-7.1) that are
expressly exempt from the provisions of subsubparagraph (i) of subparagraph (a)
of this paragraph, which alternative treatment centers shall be deemed to
concurrently hold a medical cannabis cultivator permit, a medical cannabis
manufacturer permit, and a medical cannabis dispensary permit, and shall be
authorized to engage in any conduct authorized pursuant to those permits in
relation to the cultivation, manufacturing, and dispensing of medical
cannabis.  </span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (ii) In
addition, each of the alternative treatment centers described in subsubparagraph
(i) of this subparagraph, to which the provisions of subparagraph (a) of this
paragraph shall not apply, shall, upon the adoption of the initial rules and
regulations by the commission pursuant to subparagraph (a) of paragraph (1) of
subsection d. of section 6 of P.L.2021, c.16 (C.24:6I-34), be deemed to either
concurrently hold a Class 1 Cannabis Cultivator license, a Class 2 Cannabis
Manufacturer License, a Class 5 Cannabis Retailer license, plus an additional
Class 5 Cannabis Retailer license for each satellite dispensary authorized and
established by the alternative treatment center pursuant to subparagraph (d) of
this paragraph, and a Class 6 Cannabis Delivery license, or hold a Class 3
Cannabis Wholesaler license, and may also be deemed to hold a Class 4 Cannabis
Distributor license.  Any alternative treatment center deemed to hold one or
more licenses as described in this subsubparagraph may begin to operate as any
authorized class of cannabis establishment, or establishment and delivery service,
or as a cannabis wholesaler and distributor, upon receipt of written approval
from the municipality in which the proposed establishment or delivery service,
or distributor is to be located and obtaining an initial license or licenses,
as applicable, issued by the commission pursuant to paragraph (3) of subsection
a. of section 33 of P.L.2021, c.16 (C.24:6I-46).</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (d)
(i)  No entity may be issued or concurrently hold more than one medical
cannabis cultivator permit, one medical cannabis manufacturer permit, or one
medical cannabis dispensary permit at one time</span><b><span style='font-family:
"Albertus Extra Bold",sans-serif;letter-spacing:0pt'>[</span></b><span
style='letter-spacing:0pt'>, and no medical cannabis dispensary shall be
authorized to establish a satellite location on or after the effective date of
P.L.2019, c.153 (C.24:6I-5.1 et al.),</span><b><span style='font-family:"Albertus Extra Bold",sans-serif;
letter-spacing:0pt'>]</span></b><u><span style='letter-spacing:0pt'>.</span></u><span
style='letter-spacing:0pt'>  </span><b><span style='font-family:"Albertus Extra Bold",sans-serif;
letter-spacing:0pt'>[</span></b><span style='letter-spacing:0pt'>except that an</span><b><span
style='font-family:"Albertus Extra Bold",sans-serif;letter-spacing:0pt'>]</span></b><span
style='letter-spacing:0pt'> <u>An</u> alternative treatment center </span><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>2</span></sup></b><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b><span
style='letter-spacing:0pt'>that was issued a permit prior to the effective date
of P.L.2019, c.153 (C.24:6I-5.1 et al.) or that was issued a permit after the
effective date of P.L.2019, c.153 (C.24:6I-5.1 et al.) pursuant to an
application submitted prior to the effective date of P.L.2019, c.153
(C.24:6I-5.1 et al.)</span><b><span style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b><span
style='letter-spacing:0pt'> <u>which has been issued a permit to dispense
medical cannabis from a medical cannabis dispensary</u></span><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>2</span></sup></b><span
style='letter-spacing:0pt'> shall be authorized to maintain up to two satellite
dispensaries </span><b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>2</span></sup></b><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b><span
style='letter-spacing:0pt'>, including any satellite dispensary that was
approved pursuant to an application submitted prior to or within 18 months
after the effective date of P.L.2019, c.153 (C.24:6I-5.1 et al.).  The three
alternative treatment centers issued permits pursuant to section 11 of
P.L.2019, c.153 (C.24:6I-7.1) that are expressly exempt from the provisions of
subsubparagraph (i) of subparagraph (a) of this paragraph shall be authorized
to establish and maintain up to one satellite dispensary location, provided
that the satellite dispensary was approved pursuant to an application submitted
within 18 months after the effective date of P.L.2019, c.153 (C.24:6I-5.1 et
al.)</span><b><span style='font-family:"Albertus Extra Bold",sans-serif'>]<sup>2</sup></span></b><span
style='letter-spacing:0pt'>.  <u>A medical cannabis dispensary seeking to
establish a satellite dispensary location shall obtain commission approval in
accordance with P.L.2009, c.307 (C.24:6I-1 et al.) and P.L.2021, c.16
(C.24:6I-31 et al.) and, upon commission approval, shall be authorized to
establish and maintain up to</u> </span><b><sup><span style='font-family:"Albertus Extra Bold",sans-serif;
letter-spacing:0pt'>1</span></sup></b><b><span style='font-family:"Albertus Extra Bold",sans-serif;
letter-spacing:0pt'>[</span></b><u><span style='letter-spacing:0pt'>one</span></u><b><span
style='font-family:"Albertus Extra Bold",sans-serif;letter-spacing:0pt'>]</span></b><span
style='letter-spacing:0pt'> <u>two</u></span><b><sup><span style='font-family:
"Albertus Extra Bold",sans-serif;letter-spacing:0pt'>1</span></sup></b><span
style='letter-spacing:0pt'> <u>satellite dispensary </u></span><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif;letter-spacing:0pt'>1</span></sup></b><b><span
style='font-family:"Albertus Extra Bold",sans-serif;letter-spacing:0pt'>[</span></b><u><span
style='letter-spacing:0pt'>location</span></u><b><span style='font-family:"Albertus Extra Bold",sans-serif;
letter-spacing:0pt'>]</span></b><span style='letter-spacing:0pt'> <u>locations</u></span><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif;letter-spacing:0pt'>1</span></sup></b><u><span
style='letter-spacing:0pt'>. </span></u></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (ii) Notwithstanding
the provisions of subsubparagraph (i) of this subparagraph, an investor,
investor group, or fund that provides significant financial or technical
assistance or the significant use of intellectual property, or a combination
thereof, to an applicant for a medical cannabis dispensary permit, which
applicant has been certified as a minority business pursuant to P.L.1986, c.195
(C.52:27H-21.18 et seq.), a women's business pursuant to P.L.1986, c.195
(C.52:27H-21.18 et seq.), or is a disabled-veterans' business, as defined in section
2 of P.L.2015, c.116 (C.52:32-31.2), may own up to a 35 percent interest in up
to seven entities that have been issued a medical cannabis dispensary permit,
provided that each such medical cannabis dispensary is a certified minority or
women's business or a disabled-veterans' business, and the terms of the
agreement to provide significant financial or technical assistance or the
significant use of intellectual property, or a combination thereof, whether
provided in the form of equity, a loan, or otherwise, including interest rates,
returns, and fees, are commercially reasonable based on the terms generally
provided to comparable businesses.  The terms of the agreement for the
provision of significant financial or technical assistance or the significant use
of intellectual property, or a combination thereof, may include performance,
quality, and other requirements as a condition of providing the financial or
technical assistance or use of intellectual property.  An applicant for a
medical cannabis dispensary permit that has or will receive significant
financial or technical assistance or the significant use of intellectual
property under this subsubparagraph shall include with the permit application
materials submitted to the commission a copy of the agreement to provide
significant financial or technical assistance or significant use of
intellectual property, or a combination thereof, which agreement shall be
subject to review by the commission as provided in subsection f. of section 11
of P.L.2019, c.153 (C.24:6I-7.1).</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      An
applicant for a medical cannabis dispensary permit that receives significant
financial or technical assistance or the significant use of intellectual
property under this subsubparagraph shall pay back to the investor, investor
group, or fund the full value of the financial or technical assistance or
intellectual property provided under the agreement, plus any applicable
interest and fees, in a period not less than five years after the date of the
agreement if the full value of the assistance or property is less than
$100,000, in a period not less than seven years after the date of the agreement
if the full value of the assistance or property is between $100,001 and
$250,000, in a period not less than 10 years after the date of agreement if the
full value of the assistance or property is between $250,001 and $500,000, and,
subject to any terms and conditions imposed by a lender, in a period not less
than 10 years after the date of the agreement if the full value of the
assistance or property is greater than $500,000.  An investor, investor group,
or fund that has acquired an ownership interest in one or more entities that
have been issued a medical cannabis dispensary permit as authorized under this
subsubparagraph may maintain the ownership interest after the date the full
value of the financial or technical assistance or use of intellectual property
provided under the agreement, plus interest and fees, has been repaid by the
applicant that received the assistance or use of intellectual property.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      In
no case may the controlling interest in the entity that holds a medical
cannabis dispensary permit in which an investor, investor group, or fund owns
an interest as authorized under this subsubparagraph revert to the investor,
investor group, or fund in the event of a default or failure by the certified
minority or women's business or disabled-veterans' business, as applicable, and
any such controlling interest may only be transferred to a certified minority
or women's business or a disabled-veterans' business.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      An
entity issued a medical cannabis cultivator, medical cannabis manufacturer, or
medical cannabis dispensary permit, or an individual associated with the
ownership or management of such entity, may invest in or participate in an
investor group or a fund that meets the requirements of this subsubparagraph
with respect to a Class 5 cannabis retailer license or an alternative treatment
center permit.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (e) No
entity issued a medical cannabis cultivator, medical cannabis manufacturer, or
medical cannabis dispensary permit may concurrently hold a clinical registrant
permit issued pursuant to section 13 of P.L.2019, c.153 (C.24:6I-7.3), and no
entity issued a clinical registrant permit pursuant to section 13 of P.L.2019,
c.153 (C.24:6I-7.3) may concurrently hold a medical cannabis cultivator permit,
a medical cannabis manufacturer permit, or a medical cannabis dispensary
permit.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (f)  Any
medical cannabis dispensary permit holder may be approved by the commission to
operate a cannabis consumption area, provided that the permit holder otherwise
meets the requirements of section 28 of P.L.2019, c.153 (C.24:6I-21).</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (g) An
alternative treatment center that was issued a permit prior to the effective
date of P.L.2019, c.153 (C.24:6I-5.1 et al.), that was issued a permit after
the effective date of P.L.2019, c.153 (C.24:6I-5.1 et al.) pursuant to an
application submitted pursuant to a request for applications published in the
New Jersey Register prior to the effective date of P.L.2019, c.153 (C.24:6I-5.1
et al.), or that was issued a permit after the effective date of P.L.2019,
c.153 (C.24:6I-5.1 et al.) pursuant to an application submitted prior to the
effective date of P.L.2019, c.153 (C.24:6I-5.1 et al.), shall be required to
submit an attestation signed by a bona fide labor organization stating that the
alternative treatment center has entered into a labor peace agreement with such
bona fide labor organization no later than 100 days after the effective date of
P.L.2019, c.153 (C.24:6I-5.1 et al.) or no later than 100 days after the date
the alternative treatment center first opens, whichever date is later.  The
maintenance of a labor peace agreement with a bona fide labor organization
shall be an ongoing material condition of maintaining the alternative treatment
center's permit.  The failure to submit an attestation as required pursuant to
this subparagraph within 100 days after the effective date of P.L.2019, c.153
(C.24:6I-5.1 et al.) or within 100 days after the alternative treatment center
first opens, as applicable, shall result in the suspension or revocation of the
alternative treatment center's permit, provided that the commission may grant
an extension to this deadline to the alternative treatment center based upon
extenuating circumstances or for good cause shown.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      As
used in this subparagraph, &quot;bona fide labor organization&quot; means a
labor organization of any kind or employee representation committee, group, or
association, in which employees participate and which exists and is constituted
for the purpose, in whole or in part, of collective bargaining or otherwise
dealing with medical or personal use cannabis employers concerning grievances,
labor disputes, terms or conditions of employment, including wages and rates of
pay, or other mutual aid or protection in connection with employment, and may
be characterized by: it being a party to one or more executed collective
bargaining agreements with medical or personal use cannabis employers, in this
State or another state; it having a written constitution or bylaws in the three
immediately preceding years; it filing the annual financial report required of
labor organizations pursuant to subsection (b) of 29 U.S.C. s.431, or it having
at least one audited financial report in the three immediately preceding years;
it being affiliated with any regional or national association of unions,
including but not limited to state and federal labor councils; or it being a
member of a national labor organization that has at least 500 general members
in a majority of the 50 states of the United States.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (h)
An alternative treatment center that was issued a permit prior to the effective
date of P.L.2019, c.153 (C.24:6I-5.1 et al.), that was issued a permit after
the effective date of P.L.2019, c.153 (C.24:6I-5.1 et al.) pursuant to an
application submitted pursuant to a request for applications published in the
New Jersey Register prior to the effective date of P.L.2019, c.153 (C.24:6I-5.1
et al.), or that was issued a permit after the effective date of P.L.2019,
c.153 (C.24:6I-5.1 et al.) pursuant to an application submitted prior to the
effective date of P.L.2019, c.153 (C.24:6I-5.1 et al.), shall be permitted to
cultivate from up to two physical locations, provided that the alternative
treatment center's combined mature cannabis plant grow canopy between both
locations shall not exceed 150,000 square feet of bloom space or the square
footage of canopy permitted under the largest tier in the tiered system adopted
by the commission pursuant to paragraph (2) of subsection b. of section 21 of
P.L.2021, c.16 (C.24:6I-38).</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (3) The
commission shall seek to ensure the availability of a sufficient number of
medical cannabis cultivators, medical cannabis manufacturers, and medical
cannabis dispensaries throughout the State, pursuant to need, including at
least two each in the northern, central, and southern regions of the State.
Medical cannabis cultivators, medical cannabis manufacturers, and medical
cannabis dispensaries issued permits pursuant to this section may be nonprofit
or for-profit entities.  </span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (4) The
commission shall periodically evaluate whether the number of medical cannabis
cultivator, medical cannabis manufacturer, and medical cannabis dispensary
permits issued are sufficient to meet the needs of qualifying patients in the
State, and shall accept new applications and issue such additional permits as
shall be necessary to meet those needs.  The types of permits requested and
issued, and the locations of any additional permits that are authorized, shall
be in the discretion of the commission based on the needs of qualifying
patients in the State. </span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (5) (a)
A medical cannabis cultivator shall be authorized to: acquire a reasonable
initial and ongoing inventory, as determined by the commission, of cannabis
seeds or seedlings and paraphernalia; possess, cultivate, plant, grow, harvest,
and package medical cannabis, including prerolled forms, for any authorized
purpose, including, but not limited to, research purposes; and deliver,
transfer, transport, distribute, supply, or sell medical cannabis and related
supplies to any medical cannabis cultivator, medical cannabis manufacturer,
medical cannabis dispensary, or clinical registrant in the State.  In no case
shall a medical cannabis cultivator operate or be located on land that is
valued, assessed or taxed as an agricultural or horticultural use pursuant to
the &quot;Farmland Assessment Act of 1964,&quot; P.L.1964, c.48 (C.54:4-23.1 et
seq.). </span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (b) A
medical cannabis manufacturer shall be authorized to: purchase or acquire
medical cannabis from any medical cannabis cultivator, medical cannabis
manufacturer, or clinical registrant in the State; possess and utilize medical
cannabis in the manufacture and creation of medical cannabis products; and
deliver, transfer, transport, supply, or sell medical cannabis products and
related supplies to any medical cannabis manufacturer, medical cannabis
dispensary, or clinical registrant in the State.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (c) A
medical cannabis dispensary shall be authorized to: purchase or acquire medical
cannabis from any medical cannabis cultivator, medical cannabis dispensary, or
clinical registrant in the State and medical cannabis products and related
supplies from any medical cannabis manufacturer, medical cannabis dispensary,
or clinical registrant in the State; purchase or acquire paraphernalia from any
legal source; and distribute, supply, sell, or dispense medical cannabis,
medical cannabis products, paraphernalia, and related supplies to qualifying
patients or their designated or institutional caregivers who are registered
with the commission pursuant to section 4 of P.L.2009, c.307 (C.24:6I-4).  A
medical cannabis dispensary may furnish medical cannabis, medical cannabis
products, paraphernalia, and related supplies to a medical cannabis handler for
delivery to a registered qualifying patient, designated caregiver, or
institutional caregiver consistent with the requirements of subsection i. of
section 27 of P.L.2019, c.153 (C.24:6I-20).</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (6) A
medical cannabis cultivator shall not be limited in the number of strains of
medical cannabis cultivated, and a medical cannabis manufacturer shall not be
limited in the number or type of medical cannabis products manufactured or
created.  A medical cannabis manufacturer may package, and a medical cannabis
dispensary may directly dispense medical cannabis and medical cannabis products
to qualifying patients and their designated and institutional caregivers in any
authorized form.  Authorized forms shall include dried form, oral lozenges,
topical formulations, transdermal form, sublingual form, tincture form, or
edible form, or any other form as authorized by the commission.  Edible form
shall include pills, tablets, capsules, drops or syrups, oils, chewable forms,
and any other form as authorized by the commission, except that the edible
forms made available to minor patients shall be limited to forms that are
medically appropriate for children, including pills, tablets, capsules,
chewable forms, and drops, oils, syrups, and other liquids.  </span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (7) Nonprofit
medical cannabis cultivators, medical cannabis manufacturers, and medical
cannabis dispensaries need not be recognized as a 501(c)(3) organization by the
federal Internal Revenue Service.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      b.   The
commission shall require that an applicant provide such information as the
commission determines to be necessary pursuant to regulations adopted pursuant
to P.L.2009, c.307 (C.24:6I-1 et al.).</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      c.   A
person who has been convicted of a crime of the first, second, or third degree
under New Jersey law or of a crime involving any controlled dangerous substance
or controlled substance analog as set forth in chapter 35 of Title 2C of the
New Jersey Statutes except paragraph (11) or (12) of subsection b. of
N.J.S.2C:35-5, or paragraph (3) or (4) of subsection a. of N.J.S.2C:35-10, or
any similar law of the United States or any other state shall not be issued a
permit to operate as a medical cannabis cultivator, medical cannabis
manufacturer, medical cannabis dispensary, or clinical registrant or be a
director, officer, or employee of a medical cannabis cultivator, medical
cannabis manufacturer, medical cannabis dispensary, or clinical registrant,
unless such conviction occurred after the effective date of P.L.2009, c.307
(C.24:6I-1 et al.) and was for a violation of federal law relating to possession
or sale of cannabis for conduct that is authorized under P.L.2009, c.307
(C.24:6I-1 et al.) or P.L.2015, c.158 (C.18A:40-12.22 et al.).</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      d. 
(1) The commission shall require each applicant seeking a permit to operate as,
to be a director, officer, or employee of, or to be a significantly involved
person in, a medical cannabis cultivator, medical cannabis manufacturer,
medical cannabis dispensary, or clinical registrant to undergo a criminal
history record background check. </span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      Any
individual seeking to become a director, officer, or employee of a medical
cannabis cultivator, medical cannabis manufacturer, medical cannabis
dispensary, or clinical registrant, after issuance of an initial permit shall
notify the commission and shall complete a criminal history record background
check and provide all information as may be required by the commission as a
condition of assuming a position as director, officer, or employee of the
permitted entity.  An individual who secures an investment interest or gains
the authority to make controlling decisions in a permitted entity that makes
the individual a significantly involved person shall notify the commission,
complete a criminal history record background check, and provide all
information as may be required by the commission no later than 30 days after
the date the individual becomes a significantly involved person, or any permit
issued to the individual or group of which the significantly involved person is
a member shall be revoked and the individual or group shall be deemed
ineligible to hold any ownership or investment interest in a medical cannabis
cultivator, medical cannabis manufacturer, medical cannabis dispensary, or
clinical registrant for a period of at least two years, commencing from the
date of revocation, and for such additional period of time as the commission
deems appropriate, based on the duration of the nondisclosure, the size of the
individual's or group's investment interest in the permitted entity, the amount
of profits, revenue, or income realized by the individual or group from the
permitted entity during the period of nondisclosure, and whether the individual
had a disqualifying conviction or would otherwise have been deemed ineligible
to be a significantly involved person in a medical cannabis cultivator, medical
cannabis manufacturer, medical cannabis dispensary, or clinical registrant.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      For
purposes of this section, the term &quot;applicant&quot; shall include any
owner, director, officer, or employee of, and any significantly involved person
in, a medical cannabis cultivator, medical cannabis manufacturer, medical
cannabis dispensary, or clinical registrant.  The commission is authorized to
exchange fingerprint data with and receive criminal history record background
information from the Division of State Police and the Federal Bureau of
Investigation consistent with the provisions of applicable State and federal
laws, rules, and regulations.  The Division of State Police shall forward
criminal history record background information to the commission in a timely
manner when requested pursuant to the provisions of this section.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      An
applicant who is required to undergo a criminal history record background check
pursuant to this section shall submit to being fingerprinted in accordance with
applicable State and federal laws, rules, and regulations.  No check of
criminal history record background information shall be performed pursuant to
this section unless the applicant has furnished the applicant's written consent
to that check.  An applicant who is required to undergo a criminal history
record background check pursuant to this section who refuses to consent to, or
cooperate in, the securing of a check of criminal history record background
information shall not be considered for a permit to operate, or authorization
to be employed at or to be a significantly involved person in, a medical
cannabis cultivator, medical cannabis manufacturer, medical cannabis
dispensary, or clinical registrant.  An applicant shall bear the cost for the
criminal history record background check, including all costs of administering
and processing the check.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (2) The
commission shall not approve an applicant for a permit to operate, or
authorization to be employed at or to be a significantly involved person in, a
medical cannabis cultivator, medical cannabis manufacturer, medical cannabis
dispensary, or clinical registrant if the criminal history record background
information of the applicant reveals a disqualifying conviction as set forth in
subsection c. of this section.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (3) Upon
receipt of the criminal history record background information from the Division
of State Police and the Federal Bureau of Investigation, the commission shall
provide written notification to the applicant of the applicant's qualification
or disqualification for a permit to operate or be a director, officer, or
employee of, or a significantly involved person in, a medical cannabis
cultivator, medical cannabis manufacturer, medical cannabis dispensary, or
clinical registrant.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      If
the applicant is disqualified because of a disqualifying conviction pursuant to
the provisions of this section, the conviction that constitutes the basis for
the disqualification shall be identified in the written notice.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (4) The
Division of State Police shall promptly notify the commission in the event that
an individual who was the subject of a criminal history record background check
conducted pursuant to this section is convicted of a crime or offense in this
State after the date the background check was performed.  Upon receipt of that notification,
the commission shall make a determination regarding the continued eligibility
to operate or be a director, officer, or employee of, or a significantly
involved person in, a medical cannabis cultivator, medical cannabis
manufacturer, medical cannabis dispensary, or clinical registrant.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (5) Notwithstanding
the provisions of subsection c. of this section to the contrary, the commission
may offer provisional authority for an applicant to be an owner, director,
officer, or employee of, or a significantly involved person in, a medical
cannabis cultivator, medical cannabis manufacturer, medical cannabis
dispensary, or clinical registrant for a period not to exceed three months if
the applicant submits to the commission a sworn statement attesting that the
person has not been convicted of any disqualifying conviction pursuant to this
section.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (6) Notwithstanding
the provisions of subsection c. of this section to the contrary, no applicant
to be an owner, director, officer, or employee of, or a significantly involved
person in, a medical cannabis cultivator, medical cannabis manufacturer,
medical cannabis dispensary, or clinical registrant shall be disqualified on
the basis of any conviction disclosed by a criminal history record background
check conducted pursuant to this section if the individual has affirmatively
demonstrated to the commission clear and convincing evidence of
rehabilitation.  In determining whether clear and convincing evidence of
rehabilitation has been demonstrated, the following factors shall be
considered:</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (a) the
nature and responsibility of the position which the convicted individual would
hold, has held, or currently holds;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (b) the
nature and seriousness of the crime or offense;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (c) the
circumstances under which the crime or offense occurred;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (d) the
date of the crime or offense;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (e) the
age of the individual when the crime or offense was committed;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (f)  whether
the crime or offense was an isolated or repeated incident;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (g) any
social conditions which may have contributed to the commission of the crime or
offense; and</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (h) any
evidence of rehabilitation, including good conduct in prison or in the
community, counseling or psychiatric treatment received, acquisition of
additional academic or vocational schooling, successful participation in
correctional work-release programs, or the recommendation of those who have had
the individual under their supervision.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      e.   The
commission shall issue a permit to operate or be an owner, director, officer,
or employee of, or a significantly involved person in, a medical cannabis
cultivator, medical cannabis manufacturer, or medical cannabis dispensary if
the commission finds that issuing such a permit would be consistent with the
purposes of P.L.2009, c.307 (C.24:6I-1 et al.) and the requirements of this
section and section 11 of P.L.2019, c.153 (C.24:6I-7.1) are met.  The denial of
an application shall be considered a final agency decision, subject to review
by the Appellate Division of the Superior Court.  A permit to operate a medical
cannabis cultivator, medical cannabis manufacturer, or medical cannabis
dispensary issued on or after the effective date of P.L.2019, c.153
(C.24:6I-5.1 et al.) shall be valid for one year and shall be renewable
annually.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      f.    A
person who has been issued a permit pursuant to this section or a clinical
registrant permit pursuant to section 13 of P.L.2019, c.153 (C.24:6I-7.3) shall
display the permit at the front entrance to the premises of the permitted
facility at all times when the facility is engaged in conduct authorized
pursuant to P.L.2009, c.307 (C.24:6I-1 et al.) involving medical cannabis,
including, but not limited to, the cultivating, manufacturing, or dispensing of
medical cannabis.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      g.   A
medical cannabis cultivator, medical cannabis manufacturer, medical cannabis
dispensary, or clinical registrant shall report any change in information to
the commission not later than 10 days after such change, or the permit shall be
deemed null and void.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      h.   Each
medical cannabis dispensary and clinical registrant shall maintain and make
available on its Internet website, if any, a standard price list that shall
apply to all medical cannabis, medical cannabis products, and related supplies
and paraphernalia sold or dispensed by the medical cannabis dispensary or
clinical registrant, which prices shall be reasonable and consistent with the
actual costs incurred by the medical cannabis dispensary or clinical registrant
in connection with acquiring and selling, transferring, or dispensing the
medical cannabis or medical cannabis product and related supplies and
paraphernalia.  The prices charged by the medical cannabis dispensary or
clinical registrant shall not deviate from the prices indicated on the entity's
current price list, provided that a price list maintained by a medical cannabis
dispensary or clinical registrant may allow for medical cannabis to be made
available at a reduced price or without charge to qualifying patients who have
a demonstrated financial hardship, as that term shall be defined by the
commission by regulation.  A price list required pursuant to this subsection
may be revised no more than once per month, and each medical cannabis
dispensary and clinical registrant shall be responsible for ensuring that the
commission has a copy of the facility's current price list.  A medical cannabis
dispensary or clinical registrant shall be liable to a civil penalty of $1,000
for each sale that occurs at a price that deviates from the entity's current
price list, and to a civil penalty of $10,000 for each week during which the
entity's current price list is not on file with the commission.  Any civil
penalties collected by the commission pursuant to this section shall be
deposited in the &quot;Cannabis Regulatory, Enforcement Assistance, and
Marketplace Modernization Fund&quot; established under section 41 of P.L.2021,
c.16 (C.24:6I-50), and used by the commission for the purposes of administering
the State medical cannabis program.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      i.    The
commission shall adopt regulations to:</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (1) require
such written documentation of each delivery or dispensation of cannabis to, and
pickup of cannabis for, a registered qualifying patient, including the date and
amount dispensed, and, in the case of delivery, the date and times the delivery
commenced and was completed, the address where the medical cannabis was
delivered, the name of the patient or caregiver to whom the medical cannabis
was delivered, and the name, handler certification number, and delivery
certification number of the medical cannabis handler who performed the
delivery, to be maintained in the records of the medical cannabis dispensary or
clinical registrant, as the commission determines necessary to ensure effective
documentation of the operations of each medical cannabis dispensary or clinical
registrant;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (2) monitor,
oversee, and investigate all activities performed by medical cannabis
cultivators, medical cannabis manufacturers, medical cannabis dispensaries, and
clinical registrants; </span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (3) ensure
adequate security of all facilities 24 hours per day and security of all delivery
methods to registered qualifying patients; and</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (4) establish
thresholds for administrative action to be taken against a medical cannabis
cultivator, medical cannabis manufacturer, medical cannabis dispensary, or
clinical registrant and its employees, officers, investors, directors, or
governing board pursuant to subsection m. of this section, including, but not
limited to, specific penalties or disciplinary actions that may be imposed in a
summary proceeding.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      j.    (1)
Each medical cannabis cultivator, medical cannabis manufacturer, medical
cannabis dispensary, and clinical registrant shall require the owners,
directors, officers, and employees at the permitted facility to complete at
least eight hours of ongoing training each calendar year.  The training shall
be tailored to the roles and responsibilities of the individual's job function,
and shall include training on confidentiality and such other topics as shall be
required by the commission.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (2) Each
medical cannabis dispensary and clinical registrant shall consider whether to
make interpreter services available to the population served, including for
individuals with a visual or hearing impairment.  The commission shall provide
assistance to any medical cannabis dispensary or clinical registrant that seeks
to provide such services in locating appropriate interpreter resources.  A
medical cannabis dispensary or clinical registrant shall assume the cost of
providing interpreter services pursuant to this subsection.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      k. 
(1) The first six alternative treatment centers issued permits following the
effective date of P.L.2009, c.307 (C.24:6I-1 et al.) shall be authorized to
sell or transfer such permit and other assets to a for-profit entity, provided
that:  the sale or transfer is approved by the commission; each owner,
director, officer, and employee of, and significantly involved person in, the
entity seeking to purchase or receive the transfer of the permit, undergoes a
criminal history record background check pursuant to subsection d. of this
section, provided that nothing in this subsection shall be construed to require
any individual to undergo a criminal history record background check if the
individual would otherwise be exempt from undergoing a criminal history record
background check pursuant to subsection d. of this section; the commission
finds that the sale or transfer of the permit would be consistent with the
purposes of P.L.2009, c.307 (C.24:6I-1 et al.); and no such sale or transfer
shall be authorized more than one year after the effective date of P.L.2019,
c.153 (C.24:6I-5.1 et al.).  The sale or transfer of a permit pursuant to this
subsection shall not be subject to the requirements of the &quot;New Jersey
Nonprofit Corporation Act,&quot; N.J.S.15A:1-1 et seq., provided that, prior to
or at the time of the sale or transfer, all debts and obligations of the
nonprofit entity are either paid in full or assumed by the for-profit entity
purchasing or acquiring the permit, or a reserve fund is established for the
purpose of paying in full the debts and obligations of the nonprofit entity,
and the for-profit entity pays the full value of all assets held by the
nonprofit entity, as reflected on the nonprofit entity's balance sheet, in
addition to the agreed-upon price for the sale or transfer of the entity's alternative
treatment center permit.  Until such time as the members of the Cannabis
Regulatory Commission are appointed and the commission first organizes, the
Department of Health shall have full authority to approve a sale or transfer
pursuant to this paragraph.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (2) The
sale or transfer of any interest of five percent or more in a medical cannabis
cultivator, medical cannabis manufacturer, medical cannabis dispensary, or
clinical registrant permit shall be subject to approval by the commission and
conditioned on the entity that is purchasing or receiving transfer of the
interest in the medical cannabis cultivator, medical cannabis manufacturer,
medical cannabis dispensary, or clinical registrant permit completing a
criminal history record background check pursuant to the requirements of
subsection d. of this section.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      l.    No
employee of any department, division, agency, board, or other State, county, or
local government entity involved in the process of reviewing, processing, or
making determinations with regard to medical cannabis cultivator, medical
cannabis manufacturer, medical cannabis dispensary, or clinical registrant
permit applications shall have any direct or indirect financial interest in the
cultivating, manufacturing, or dispensing of medical cannabis or related
paraphernalia, or otherwise receive anything of value from an applicant for a
medical cannabis cultivator, medical cannabis manufacturer, medical cannabis
dispensary, or clinical registrant permit in exchange for reviewing,
processing, or making any recommendations with respect to a permit application.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      m.  In
the event that a medical cannabis cultivator, medical cannabis manufacturer,
medical cannabis dispensary, or clinical registrant fails to comply with any
requirements set forth in P.L.2009, c.307 (C.24:6I-1 et al.) or any related law
or regulation, the commission may invoke penalties or take administrative
action against the medical cannabis cultivator, medical cannabis manufacturer,
medical cannabis dispensary, or clinical registrant and its employees,
officers, investors, directors, or governing board, including, but not limited
to, assessing fines, referring matters to another State agency, and suspending
or terminating any permit held by the medical cannabis cultivator, medical cannabis
manufacturer, medical cannabis dispensary, or clinical registrant.  Any
penalties imposed or administrative actions taken by the commission pursuant to
this subsection may be imposed in a summary proceeding.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>(cf:
P.L.2023, c.162, s.3)</span></p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      </span><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>2</span></sup></b><span
style='letter-spacing:0pt'>2. Section 31 of P.L.2019, c.153 (C.24:6I-24) is
amended to read as follows: </span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      31.
a. The Cannabis Regulatory Commission is hereby created in, but not of, the
Department of the Treasury, to:</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (1) assume
all powers, duties, and responsibilities with regard to the regulation and
oversight of activities authorized pursuant to P.L.2009, c.307 (C.24:6I-1 et
al.) from the Department of Health for the further development, expansion,
regulation, and enforcement of activities associated with the medical use of
cannabis pursuant to P.L.2009, c.307 (C.24:6I-1 et al.).  All powers, duties,
and responsibilities with regard to the regulation and oversight of activities
authorized pursuant to P.L.2009, c.307 (C.24:6I-1 et al.) shall be transferred
from the Department of Health to the Cannabis Regulatory Commission at such
time as the members of the commission are appointed as provided in subsection
b. of this section and the commission first organizes.  Thereafter, any
reference to the Department of Health or the Commissioner of Health in any
statute or regulation pertaining to the provisions of P.L.2009, c.307
(C.24:6I-1 et al.) shall be deemed to refer to the Cannabis Regulatory
Commission.  The provisions of this paragraph shall be carried out in
accordance with the &quot;State Agency Transfer Act,&quot; P.L.1971, c.375
(C.52:14D-1 et seq.); and</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (2) oversee
the development, regulation, and enforcement of activities associated with the
personal use of cannabis pursuant to P.L.2021, c.16 (C.24:6I-31 et al.).</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      b.
(1) The commission shall consist of five members, one of whom shall be
designated by the Governor as the chair, and one of whom shall be designated
the vice-chair in accordance with the appointment process set forth in
paragraph (7) of this subsection. </span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (2) The
members of the commission shall be <u>directly</u> appointed </span><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b><span
style='letter-spacing:0pt'>by the Governor</span><b><span style='font-family:
"Albertus Extra Bold",sans-serif'>]</span></b><span style='letter-spacing:0pt'>
as follows:</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (a) One
member shall be appointed </span><b><span style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b><span
style='letter-spacing:0pt'>upon recommendation of</span><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b><span
style='letter-spacing:0pt'> <u>by</u> the Senate President;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (b) One
member shall be appointed </span><b><span style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b><span
style='letter-spacing:0pt'>upon recommendation of</span><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b><span
style='letter-spacing:0pt'> <u>by</u> the Speaker of the General Assembly;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (c) Three
members, including the chair, shall be appointed </span><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b><span
style='letter-spacing:0pt'>without any needed recommendation</span><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b><span
style='letter-spacing:0pt'> <u>by the Governor</u>.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (3) Initial
appointments of commission members pursuant to paragraph (2) of this subsection
shall not require the advice and consent of the Senate.  Subsequent
appointments made pursuant to subparagraph (c) of paragraph (2) of this
subsection, including reappointments of members initially appointed, shall be
made with the advice and consent of the Senate.  Subsequent appointments made
pursuant to subparagraphs (a) and (b) of paragraph (2) of this subsection shall
be made in the same manner as the original appointment.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (4) All
five members shall be residents of this State.  At least one member shall be a
State representative of a national organization or State branch of a national
organization with a stated mission of studying, advocating, or adjudicating
against minority historical oppression, past and present discrimination,
unemployment, poverty and income inequality, and other forms of social
injustice or inequality, and all five members shall possess education,
training, or experience with legal, policy, or criminal justice issues,
corporate or industry management, finance, securities, or production or
distribution, medicine or pharmacology, or public health, mental health, or
substance use disorders.  </span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (5) The
chair and the other members shall serve for terms of five years; provided that,
for the two other members initially appointed by the Governor without any
needed recommendation, one shall be appointed for a term of four years, and one
shall be appointed for a term of three years.  The chair and the other members
shall serve in their respective capacities throughout their entire term and
until their successors shall have been duly appointed and qualified.  Any
vacancy in the commission occurring for any reason other than the expiration of
a term, including a vacancy occurring during the term of the initial chair or
another initial member, shall be filled in accordance with the requirements for
subsequent appointments set forth in paragraph (3) of this subsection for the
remainder of the unexpired term only.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (6) <u>(a)</u>
The chair and other members of the commission shall devote full time to their
respective duties of office and shall not pursue or engage in any other
business, occupation, or gainful employment.  Each member shall receive an
annual salary to be fixed and established by the Governor, which for the chair
shall not exceed $141,000, and for the other members shall not exceed $125,000.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      <u>(b) Notwithstanding
subparagraph (a) of this paragraph, a member may hold local elected office,
provided that, in the judgment of the State Ethics Commission and Local Finance
Board of the Department of Community Affairs, such office or employment will
not interfere with the members responsibilities to the commission, and will
not create a conflict of interest, or reasonable risk of the public perception
of a conflict of interest, on the part of the member. </u></span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (7) The
members of the commission, at the commission's first meeting when called by the
chair, shall elect, by a majority of the total authorized membership of the
commission, one of the members who is appointed based upon the recommendation
of the Senate President or Speaker of the General Assembly as set forth in
paragraph (2) of this subsection to serve as vice-chair during that member's
term.  A new vice-chair shall be elected upon the expiration of the current
vice-chair's term, even if that member remains on the commission until that
member's successor is duly appointed and qualified.  The vice-chair shall be
empowered to carry out all of the responsibilities of the chair during the
chair's absence, disqualification, or inability to serve.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (8) A
majority of the total authorized membership of the commission shall be required
to establish a quorum, and a majority of the total authorized membership of the
commission shall be required to exercise its powers at any meeting thereof. 
However, only if all five commissioners have been duly appointed in accordance
with the appointment process set forth in paragraph (2) of this subsection, and
five appointed commissioners are present at a meeting, may a majority of the
total authorized membership act to assume the powers, duties, and
responsibilities with regard to the regulation and oversight of activities
authorized pursuant to P.L.2009, c.307 (C.24:6I-1 et al.) from the Department
of Health; and similarly, only if all five appointed commissioners are present
at a meeting, may a majority of the total authorized membership act to adopt
the commission's initial rules and regulations concerning personal use cannabis
pursuant to subparagraph (a) of paragraph (1) of subsection d. of section 6 of
P.L.2021, c.16 (C.24:6I-34), by which the licensing of cannabis establishments,
distributors, and delivery services, and the lawfully permitted licensing
activities of those establishments, distributors, and delivery services may
begin.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (9) The
commission shall adopt annually a schedule of regular meetings, and special
meetings may be held at the call of the chair.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (10)
Any member of the commission may be removed from office by the Governor, for
cause, upon notice and opportunity to be heard at a public hearing.  Any member
of the commission shall automatically forfeit the member's office upon
conviction for any crime.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      c.
(1) The commission shall establish, and from time to time alter, a plan of
organization, and employ personnel as it deems necessary under the direct
supervision of a full-time executive director for the commission.  The plan of
organization shall include the Office of Minority, Disabled Veterans, and Women
Cannabis Business Development established by section 32 of P.L.2019, c.153
(C.24:6I-25).</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (a) The
initial executive director shall be appointed by the Governor, and thereafter
every subsequent executive director shall be appointed by the Governor with the
advice and consent of the Senate.  The executive director shall serve at the
pleasure of the appointing Governor during the Governor's term of office and
until a successor has been duly appointed and qualified.  Any vacancy in the
office occurring for any reason other than the expiration of a term, including
a vacancy occurring during the term of the initial executive director, shall be
filled for the unexpired term only in the same manner as the appointment of any
subsequent executive director as set forth herein.  The executive director
shall receive an annual salary to be fixed and established by the Governor,
which shall not exceed $141,000.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (b)
(i) All employees of the commission under the direct supervision of the
executive director, except for secretarial and clerical personnel, shall be in
the State's unclassified service.  All employees shall be deemed confidential
employees for the purposes of the &quot;New Jersey Employer-Employee Relations
Act,&quot; P.L.1941, c.100 (C.34:13A-1 et seq.).</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (ii) If,
as a result of transferring powers, duties, and responsibilities with regard to
the regulation and oversight of activities authorized pursuant to P.L.2009,
c.307 (C.24:6I-1 et al.) from the Department of Health to the commission
pursuant to subsection a. of this section, the commission needs to employ an
individual to fill a position, employees of the department who performed the
duties of the position to be filled shall be given a one-time right of first
refusal offer of employment with the commission, and such employees may be
removed by the commission for cause or if deemed unqualified to hold the
position, notwithstanding any other provision of law to the contrary.  A
department employee who becomes employed by the commission shall retain as an
employee of the commission the seniority, and all rights related to seniority,
that the employee had with the department as of the last day of employment with
the department; provided, however, that such seniority and seniority rights
shall be retained only by an employee who was transferred from employment with
the department to employment with the commission, and shall not be retained by
an employee who was removed from employment with the department due to layoff
procedures or who resigned from a position with the department prior to being
hired by the commission. </span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (2) The
commission may sue and be sued in any court, employ legal counsel to represent
the commission in any proceeding to which it is a party and render legal advice
to the commission upon its request, as well as contract for the services of
other professional, technical, and operational personnel and consultants as may
be necessary to the performance of its responsibilities.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (3) The
commission may incur additional expenses within the limits of funds available
to it in order to carry out its duties, functions, and powers under P.L.2009,
c.307 (C.24:6I-1 et al.) and P.L.2021, c.16 (C.24:6I-31 et al.).</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      d.   With
respect to the activities of the commission, neither the President of the
Senate or the Speaker of the General Assembly shall be permitted to appear or
practice or act in any capacity whatsoever before the commission regarding any
matter whatsoever, nor shall any member of the immediate family of the
Governor, President of the Senate, or Speaker of the General Assembly be
permitted to so practice or appear in any capacity whatsoever before the
commission regarding any matter whatsoever.  As used in this subsection,
&quot;immediate family&quot; means the spouse, domestic partner, or civil union
partner, and any dependent child or stepchild, recognized by blood or by law,
of the Governor, President of the Senate, or Speaker of the General Assembly,
or of the spouse, domestic partner, or civil union partner residing in the same
household as the Governor, President of the Senate, or Speaker of the General
Assembly.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      e.   The
commission may designate its powers and authority as it deems necessary and
appropriate to carry out its duties and implement the provisions of P.L.2009,
c.307 (C.24:6I-1 et al.) and P.L.2021, c.16 (C.24:6I-31 et al.).</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      f.    The
commission shall, no later than three years after the date it first organizes,
contract with a public research university, as defined in section 3 of
P.L.1994, c.48 (C.18A:3B-3), to conduct an independent study to review:</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (1) the
commission's organization;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (2) the
commission's regulation and enforcement activities;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (3) the
overall effectiveness of the commission as a full time entity; and</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (4) whether
the regulation and oversight of medical cannabis or personal use cannabis could
be more effectively and efficiently managed through a reorganization of the
commission, consolidation of the commission within the Department of Health or
another Executive Branch department, conversion to a part-time commission, or
the transfer of some or all of the commission's operations elsewhere within the
Executive Branch.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      The
commission shall submit the findings of the independent study, along with the
commission's recommendations for appropriate executive, administrative, or
legislative action, to the Governor and, pursuant to section 2 of P.L.1991,
c.164 (C.52:14-19.1), to the Legislature.</span><b><sup><span style='font-family:
"Albertus Extra Bold",sans-serif'>2</span></sup></b></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>(cf:
P.L.2021, c.16, s.5)</span></p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      </span><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>2</span></sup></b><span
style='letter-spacing:0pt'>3. Section 4 of P.L.1981, c.142 (C.52:13D-17.2) is
amended to read as follows: </span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      4.
a. As used in this section &quot;person&quot; means:</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (1)
(a) with respect to casino activity, activity related to medical cannabis
authorized pursuant to P.L.2009, c.307 (C.24:6I-1 et al.), and activity related
to personal use cannabis authorized pursuant to P.L.2021, c.16 (C.24:6I-31 et
al.): the Governor; the President of the Senate; the Speaker of the General
Assembly; any full-time member of the Judiciary; any full-time professional
employee of the Office of the Governor; the head of a principal department; the
assistant or deputy heads of a principal department, including all assistant
and deputy commissioners; the head of any division of a principal department;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (b) with
respect to casino activity: any State officer or employee subject to financial
disclosure by law or executive order and any other State officer or employee
with responsibility for matters affecting casino activity; any special State
officer or employee with responsibility for matters affecting casino activity;
any member of the Legislature; any full-time professional employee of the
Legislature; members of the Casino Reinvestment Development Authority; or</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (c) with
respect to activity related to medical cannabis authorized pursuant to
P.L.2009, c.307 (C.24:6I-1 et al.) and activity related to personal use
cannabis authorized pursuant to P.L.2021, c.16 (C.24:6I-31 et al.): any State
officer or employee subject to financial disclosure by law or executive order
and any other State officer or employee with responsibility for matters
affecting medical cannabis activity or personal use cannabis activity; any
special State officer or employee with responsibility for matters affecting
medical cannabis activity or personal use cannabis activity; members of the
Cannabis Regulatory Commission; or</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (2)
(a) any member of the governing body, or the municipal judge or the municipal
attorney of a municipality wherein a casino is located; any member of or
attorney for the planning board or zoning board of adjustment of a municipality
wherein a casino is located, or any professional planner, or consultant
regularly employed or retained by such planning board or zoning board of
adjustment; or</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (b) any
member of the governing body or the municipal judge of a municipality, any
member of the planning board or zoning board of adjustment, or any professional
planner, or consultant regularly employed or retained by such planning board or
zoning board of adjustment, of a municipality wherein a medical cannabis
cultivator, medical cannabis manufacturer, medical cannabis dispensary, or
clinical registrant issued a permit pursuant to P.L.2009, c.307 (C.24:6I-1 et
al.), or wherein a cannabis cultivator, cannabis manufacturer, cannabis
wholesaler, cannabis distributor, cannabis retailer, or cannabis delivery
service issued a license pursuant to P.L.2021, c.16 (C.24:6I-31 et al.), is
located.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      b.
(1) No State officer or employee, nor any person, nor any member of the
immediate family of any State officer or employee, or person, nor any
partnership, firm, or corporation with which any such State officer or employee
or person is associated or in which he has an interest, nor any partner,
officer, director, or employee while he is associated with such partnership,
firm, or corporation, shall hold, directly or indirectly, an interest in, or
hold employment with, or represent, appear for, or negotiate on behalf of, any
holder of, or applicant for, a casino license, or any holding or intermediary
company with respect thereto, in connection with any cause, application, or
matter, except as provided in section 3 of P.L.2009, c.26 (C.52:13D-17.3), and
except that (a) a State officer or employee other than a State officer or
employee included in the definition of person, and (b) a member of the
immediate family of a State officer or employee, or of a person, may hold
employment with the holder of, or applicant for, a casino license if, in the
judgment of the State Ethics Commission, the Joint Legislative Committee on
Ethical Standards, or the Supreme Court, as appropriate, such employment will
not interfere with the responsibilities of the State officer or employee, or
person, and will not create a conflict of interest, or reasonable risk of the
public perception of a conflict of interest, on the part of the State officer
or employee, or person.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      No
special State officer or employee without responsibility for matters affecting
casino activity, excluding those serving in the Departments of Education,
Health, and Human Services and the Office of the Secretary of Higher Education,
shall hold, directly or indirectly, an interest in any holder of, or applicant
for, a casino license, or any holding or intermediary company with respect
thereto.  However, a special State officer or employee without responsibility
for matters affecting casino activity may hold employment directly with, or may
represent, appear for, or negotiate on behalf of, any holder of or applicant
for a casino license or any holding or intermediary company thereof and if so
employed may hold, directly or indirectly, an interest in, or represent, appear
for, or negotiate on behalf of, that employer, except as otherwise prohibited
by law.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (2) No
State officer or employee, nor any person, nor any member of the immediate
family of any State officer or employee, or person, nor any partnership, firm,
or corporation with which any such State officer or employee or person is
associated or in which he has an interest, nor any partner, officer, director,
or employee while he is associated with such partnership, firm, or corporation,
shall hold, directly or indirectly, an interest in, or hold employment with, or
represent, appear for, or negotiate on behalf of, or derive any remuneration,
payment, benefit, or any other thing of value for any services, including but
not limited to consulting or similar services, from any holder of, or applicant
for, a license, permit, or other approval to conduct Internet gaming, or any
holding or intermediary company with respect thereto, or any Internet gaming
affiliate of any holder of, or applicant for, a casino license, or any holding
or intermediary company with respect thereto, or any business, association,
enterprise, or other entity that is organized, in whole or in part, for the
purpose of promoting, advocating for, or advancing the interests of the
Internet gaming industry generally or any Internet gaming-related business or
businesses in connection with any cause, application, or matter, except as
provided in section 3 of P.L.2009, c.26 (C.52:13D-17.3), and except that (a) a
State officer or employee other than a State officer or employee included in
the definition of person, and (b) a member of the immediate family of a State
officer or employee, or of a person, may hold employment with the holder of, or
applicant for, a license, permit, or other approval to conduct Internet gaming,
or any holding or intermediary company with respect thereto, or any Internet
gaming affiliate of any holder of, or applicant for, a casino license, or any
holding or intermediary company with respect thereto if, in the judgment of the
State Ethics Commission, the Joint Legislative Committee on Ethical Standards,
or the Supreme Court, as appropriate, such employment will not interfere with
the responsibilities of the State officer or employee, or person, and will not
create a conflict of interest, or reasonable risk of the public perception of a
conflict of interest, on the part of the State officer or employee, or person.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (3) No
State officer or employee, nor any person, nor any member of the immediate
family of any State officer or employee, or person, nor any partnership, firm,
or corporation with which any such State officer or employee or person is
associated or in which he has an interest, nor any partner, officer, director,
or employee while he is associated with such partnership, firm, or corporation,
shall hold, directly or indirectly, an interest in, or hold employment with, or
represent, appear for, or negotiate on behalf of, any holder of, or applicant
for, a medical cannabis cultivator, medical cannabis manufacturer, medical
cannabis dispensary, or clinical registrant permit issued pursuant to P.L.2009,
c.307 (C.24:6I-1 et al.) or any entity that employs any certified medical
cannabis handler to perform transfers or deliveries of medical cannabis, or any
holding or intermediary company with respect thereto, or a cannabis cultivator,
cannabis manufacturer, cannabis wholesaler, cannabis distributor, cannabis
retailer, or cannabis delivery service license issued pursuant to P.L.2021,
c.16 (C.24:6I-31 et al.), or any entity that employs or uses a certified
personal use cannabis handler to perform work for or on behalf of a licensed
cannabis establishment, distributor, or delivery service, or any holding or
intermediary company with respect thereto, in connection with any cause,
application, or matter, except as provided in section 3 of P.L.2009, c.26
(C.52:13D-17.3), and except that (a) a State officer or employee other than a
State officer or employee included in the definition of person, and (b) a
member of the immediate family of a State officer or employee, or of a person,
may hold employment with the holder of, or applicant for, a medical cannabis
cultivator, medical cannabis manufacturer, medical cannabis dispensary, or
clinical registrant permit or any entity that employs any certified medical
cannabis handler to perform transfers or deliveries of medical cannabis, or a
cannabis cultivator, cannabis manufacturer, cannabis wholesaler, cannabis
distributor, cannabis retailer, or cannabis delivery service license or any
entity that employs or uses a certified personal use cannabis handler to
perform work for or on behalf of a licensed cannabis establishment,
distributor, or delivery service, if, in the judgment of the State Ethics
Commission, the Joint Legislative Committee on Ethical Standards, or the
Supreme Court, as appropriate, such employment will not interfere with the
responsibilities of the State officer or employee, or person, and will not
create a conflict of interest, or reasonable risk of the public perception of a
conflict of interest, on the part of the State officer or employee, or person.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      No
special State officer or employee without responsibility for matters affecting
medical cannabis activity or personal use cannabis activity , excluding those
serving in the Departments of Education, Health, and Human Services and the
Office of the Secretary of Higher Education, shall hold, directly or
indirectly, an interest in any holder of, or applicant for, a medical cannabis
cultivator, medical cannabis manufacturer, medical cannabis dispensary, or
clinical registrant permit or any entity that employs any certified medical
cannabis handler to perform transfers or deliveries of medical cannabis, or any
holding or intermediary company with respect thereto, or a cannabis cultivator,
cannabis manufacturer, cannabis wholesaler, cannabis distributor, cannabis
retailer, or cannabis delivery service license or any entity that employs or
uses a certified personal use cannabis handler to perform work for or on behalf
of a licensed cannabis establishment, distributor, or delivery service, or any
holding or intermediary company with respect thereto.  However, a special State
officer or employee without responsibility for matters affecting medical
cannabis activity or personal use cannabis activity may hold employment directly
with, or may represent, appear for, or negotiate on behalf of, any holder of or
applicant for a medical cannabis cultivator, medical cannabis manufacturer,
medical cannabis dispensary, or clinical registrant permit, or any entity that
employs any certified medical cannabis handler to perform transfers or
deliveries of medical cannabis, or any holding or intermediary company thereof,
or a cannabis cultivator, cannabis manufacturer, cannabis wholesaler, cannabis
distributor, cannabis retailer, or cannabis delivery service license or any
entity that employs or uses a certified personal use cannabis handler to
perform work for or on behalf of a licensed cannabis establishment,
distributor, or delivery service, or any holding or intermediary company with
respect thereto, and if so employed may hold, directly or indirectly, an
interest in, or represent, appear for, or negotiate on behalf of, that
employer, except as otherwise prohibited by law.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      c.
(1) No person or any member of his immediate family, nor any partnership, firm,
or corporation with which such person is associated or in which he has an
interest, nor any partner, officer, director, or employee while he is
associated with such partnership, firm or corporation, shall, within two years
next subsequent to the termination of the office or employment of such person,
hold, directly or indirectly, an interest in, or hold employment with, or
represent, appear for, or negotiate on behalf of, any holder of, or applicant
for, a casino license in connection with any cause, application or matter, or
any holding or intermediary company with respect to such holder of, or
applicant for, a casino license in connection with any phase of casino
development, permitting, licensure, or any other matter whatsoever related to
casino activity, except as provided in section 3 of P.L.2009, c.26
(C.52:13D-17.3), and except that:</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (a) a
member of the immediate family of a person may hold employment with the holder
of, or applicant for, a casino license if, in the judgment of the State Ethics
Commission, the Joint Legislative Committee on Ethical Standards, or the
Supreme Court, as appropriate, such employment will not interfere with the
responsibilities of the person and will not create a conflict of interest, or
reasonable risk of the public perception of a conflict of interest, on the part
of the person;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (b) an
employee who is terminated as a result of a reduction in the workforce at the
agency where employed, other than an employee who held a policy-making
management position at any time during the five years prior to termination of
employment, may, at any time prior to the end of the two-year period, accept
employment with the holder of, or applicant for, a casino license if, in the
judgment of the State Ethics Commission, the Joint Legislative Committee on
Ethical Standards, or the Supreme Court, as appropriate, such employment will
not create a conflict of interest, or reasonable risk of the public perception
of a conflict of interest, on the part of the employee. In no case shall the
restrictions of this subsection apply to a secretarial or clerical employee. </span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      Nothing
herein contained shall alter or amend the post-employment restrictions
applicable to members and employees of the Casino Control Commission and
employees and agents of the Division of Gaming Enforcement pursuant to
paragraph (2) of subsection e. of section 59 and section 60 of P.L.1977, c.110
(C.5:12-59 and C.5:12-60); and</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (c) any
partnership, firm, or corporation engaged in the practice of law or in
providing any other professional services with which any person included in
subparagraphs (a) and (b) of paragraph (1) of subsection a. of this section, or
a member of the immediate family of that person, is associated, and any
partner, officer, director, or employee thereof, other than that person, or
immediate family member, may represent, appear for or negotiate on behalf of
any holder of, or applicant for, a casino license in connection with any cause,
application or matter or any holding company or intermediary company with
respect to such holder of, or applicant for, a casino license in connection
with any phase of casino development, permitting, licensure or any other matter
whatsoever related to casino activity, and that person or immediate family
member shall not be barred from association with such partnership, firm or
corporation, if for a period of two years next subsequent to the termination of
the person's office or employment, the person or immediate family member (i) is
screened from personal participation in any such representation, appearance or
negotiation; and (ii) is associated with the partnership, firm or corporation
in a position which does not entail any equity interest in the partnership,
firm or corporation.  The exception provided in this subparagraph shall not
apply to a former Governor, Lieutenant Governor, Attorney General, member of
the Legislature, person included in subparagraph (a) of paragraph (2) of
subsection a. of this section, or to the members of their immediate families.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (2) No
person or any member of the person's immediate family, nor any partnership,
firm, or corporation with which such person is associated or in which the
person has an interest, nor any partner, officer, director, or employee while
the person is associated with such partnership, firm, or corporation, shall,
within two years next subsequent to the termination of the office or employment
of such person, hold, directly or indirectly, an interest in, or hold
employment with, or represent, appear for, or negotiate on behalf of, any
holder of, or applicant for, a medical cannabis cultivator, medical cannabis
manufacturer, medical cannabis dispensary, or clinical registrant permit issued
pursuant to P.L.2009, c.307 (C.24:6I-1 et al.) or any entity that employs any
certified medical cannabis handler to perform transfers or deliveries of
medical cannabis, or a cannabis cultivator, cannabis manufacturer, cannabis
wholesaler, cannabis distributor, cannabis retailer, or cannabis delivery
service license issued pursuant to P.L.2021, c.16 (C.24:6I-31 et al.) or any
entity that employs or uses a certified personal use cannabis handler to
perform work for or on behalf of a licensed cannabis establishment,
distributor, or delivery service in connection with any cause, application, or
matter, or any holding or intermediary company with respect to such holder of,
or applicant for, a medical cannabis cultivator, medical cannabis manufacturer,
medical cannabis dispensary, or clinical registrant permit or any entity that
employs any certified medical cannabis handler to perform transfers or
deliveries of medical cannabis, or a cannabis cultivator, cannabis
manufacturer, cannabis wholesaler, cannabis distributor, cannabis retailer, or
cannabis delivery service license or any entity that employs or uses a
certified personal use cannabis handler to perform work for or on behalf of a
licensed cannabis establishment, distributor, or delivery service in connection
with any phase of development, permitting, licensure, or any other matter
whatsoever related to medical cannabis activity or personal use cannabis
activity, except as provided in section 3 of P.L.2009, c.26 (C.52:13D-17.3),
and except that:</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (a) a
member of the immediate family of a person may hold employment with the holder
of, or applicant for, a medical cannabis cultivator, medical cannabis
manufacturer, medical cannabis dispensary, or clinical registrant permit issued
pursuant to P.L.2009, c.307 (C.24:6I-1 et al.) or any entity that employs any
certified medical cannabis handler to perform transfers or deliveries of
medical cannabis, or a cannabis cultivator, cannabis manufacturer, cannabis
wholesaler, cannabis distributor, cannabis retailer, or cannabis delivery
service license issued pursuant to P.L.2021, c.16 (C.24:6I-31 et al.) or any
entity that employs or uses a certified personal use cannabis handler to
perform work for or on behalf of a licensed cannabis establishment,
distributor, or delivery service if, in the judgment of the State Ethics
Commission, the Joint Legislative Committee on Ethical Standards, or the
Supreme Court, as appropriate, such employment will not interfere with the
responsibilities of the person and will not create a conflict of interest, or
reasonable risk of the public perception of a conflict of interest, on the part
of the person;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (b) an
employee who is terminated as a result of a reduction in the workforce at the
agency where employed, other than an employee who held a policy-making
management position at any time during the five years prior to termination of
employment, may, at any time prior to the end of the two-year period, accept
employment with the holder of, or applicant for, a medical cannabis cultivator,
medical cannabis manufacturer, medical cannabis dispensary, or clinical
registrant permit or any entity that employs any certified medical cannabis
handler to perform transfers or deliveries of medical cannabis, or a cannabis
cultivator, cannabis manufacturer, cannabis wholesaler, cannabis distributor,
cannabis retailer, or cannabis delivery service license or any entity that
employs or uses a certified personal use cannabis handler to perform work for
or on behalf of a licensed cannabis establishment, distributor, or delivery
service if, in the judgment of the State Ethics Commission, the Joint Legislative
Committee on Ethical Standards, or the Supreme Court, as appropriate, such
employment will not create a conflict of interest, or reasonable risk of the
public perception of a conflict of interest, on the part of the employee.  In
no case shall the restrictions of this subsection apply to a secretarial or
clerical employee.  Nothing herein contained shall alter or amend the
post-service or post-employment restrictions applicable to members and
employees of the Cannabis Regulatory Commission pursuant to paragraph (2) of
subsection c. of section 34 and section 35 of P.L.2019, c.153 (C.24:6I-27 and
C.24:6I-28); and</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (c) any
partnership, firm, or corporation engaged in the practice of law or in
providing any other professional services with which any person included in
subparagraphs (a) and (c) of paragraph (1) of subsection a. of this section, or
a member of the immediate family of that person, is associated, and any
partner, officer, director, or employee thereof, other than that person, or
immediate family member, may represent, appear for, or negotiate on behalf of
any holder of, or applicant for, a medical cannabis cultivator, medical
cannabis manufacturer, medical cannabis dispensary, or clinical registrant
permit or any entity that employs any certified medical cannabis handler to
perform transfers or deliveries of medical cannabis, or a cannabis cultivator,
cannabis manufacturer, cannabis wholesaler, cannabis distributor, cannabis
retailer, or cannabis delivery service license or any entity that employs or
uses a certified personal use cannabis handler to perform work for or on behalf
of a licensed cannabis establishment, distributor, or delivery service in
connection with any cause, application, or matter or any holding company or
intermediary company with respect to such holder of, or applicant for, a
medical cannabis cultivator, medical cannabis manufacturer, medical cannabis
dispensary, or clinical registrant permit or any entity that employs any
certified medical cannabis handler to perform transfers or deliveries of
medical cannabis, or a cannabis cultivator, cannabis manufacturer, cannabis
wholesaler, cannabis distributor, cannabis retailer, or cannabis delivery
service license or any entity that employs or uses a certified personal use
cannabis handler to perform work for or on behalf of a licensed cannabis
establishment, distributor, or delivery service in connection with any phase of
development, permitting, licensing, or any other matter whatsoever related to
medical cannabis activity or personal use cannabis activity, and that person or
immediate family member shall not be barred from association with such
partnership, firm, or corporation, if for a period of </span><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b><span
style='letter-spacing:0pt'>two years</span><b><span style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b><span
style='letter-spacing:0pt'> <u>one year</u> next subsequent to the termination
of the person's office or employment, the person or immediate family member </span><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b><span
style='letter-spacing:0pt'>(i)</span><b><span style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b><span
style='letter-spacing:0pt'> is screened from personal participation in any such
representation, appearance or negotiation</span><b><span style='font-family:
"Albertus Extra Bold",sans-serif'>[</span></b><span style='letter-spacing:0pt'>;
and (ii) is associated with the partnership, firm, or corporation in a position
which does not entail any equity interest in the partnership, firm, or
corporation</span><b><span style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b><span
style='letter-spacing:0pt'>.  The exception provided in this subparagraph shall
not apply to a former Governor, Lieutenant Governor, Attorney General, the
President of the Senate, the Speaker of the General Assembly, to a person
included in subparagraph (b) of paragraph (2) of subsection a. of this section,
or to the members of their immediate families.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      d.   This
section shall not apply to the spouse of a State officer or employee, which
State officer or employee is without responsibility for matters affecting
casino, medical cannabis, or personal use cannabis activity, who becomes the
spouse subsequent to the State officer's or employee's appointment or
employment as a State officer or employee and who is not individually or directly
employed by a holder of, or applicant for, a casino license, medical cannabis
permit, personal use cannabis license, or any entity that employs or uses a
certified personal use cannabis handler to perform work for or on behalf of a
licensed cannabis establishment, distributor, or delivery service, or any
holding or intermediary company thereof.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      e.   The
Joint Legislative Committee on Ethical Standards and the State Ethics
Commission, as appropriate, shall forthwith determine and publish, and periodically
update, a list of those positions in State government with responsibility for
matters affecting casino, medical cannabis activity, or personal use cannabis
activity.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      f.
(1) No person shall solicit or accept, directly or indirectly, any
complimentary service or discount from any casino applicant or licensee which
he knows or has reason to know is other than a service or discount that is
offered to members of the general public in like circumstance.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (2) No
person shall solicit or accept, directly or indirectly, any complimentary
service or discount from any holder of, or applicant for, a medical cannabis
cultivator, medical cannabis manufacturer, medical cannabis dispensary, or
clinical registrant permit issued pursuant to P.L.2009, c.307 (C.24:6I-1 et al.)
or any entity that employs any certified medical cannabis handler to perform
transfers or deliveries of medical cannabis, or a cannabis cultivator, cannabis
manufacturer, cannabis wholesaler, cannabis distributor, cannabis retailer, or
cannabis delivery service license issued pursuant to P.L.2021, c.16 (C.24:6I-31
et al.) or any entity that employs or uses a certified personal use cannabis
handler to perform work for or on behalf of a licensed cannabis establishment,
distributor, or delivery service which the person knows or has reason to know
is other than a service or discount that is offered to members of the general
public in like circumstance.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      g.
(1) No person shall influence, or attempt to influence, by use of his official
authority, the decision of the Casino Control Commission or the investigation
of the Division of Gaming Enforcement in any application for casino licensure
or in any proceeding to enforce the provisions of this act or the regulations
of the commission. Any such attempt shall be promptly reported to the Attorney
General; provided, however, that nothing in this section shall be deemed to
proscribe a request for information by any person concerning the status of any
application for licensure or any proceeding to enforce the provisions of this
act or the regulations of the commission.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      (2) No
person shall influence, or attempt to influence, by use of the person's
official authority, the decision of the Cannabis Regulatory Commission in any
application for a medical cannabis cultivator, medical cannabis manufacturer,
medical cannabis dispensary, or clinical registrant permit, or a cannabis
cultivator, cannabis manufacturer, cannabis wholesaler, cannabis distributor,
cannabis retailer, or cannabis delivery service license, or in any proceeding
to enforce the provisions of P.L.1981, c.142 (C.52:13D-17.2 et al.), P.L.2009,
c.307 (C.24:6I-1 et al.), P.L.2021, c.16 (C.24:6I-31 et al.), or the
regulations of the Cannabis Regulatory Commission.  Any such attempt shall be
promptly reported to the Attorney General; provided, however, that nothing in
this section shall be deemed to proscribe a request for information by any
person concerning the status of any permit or license application, or any
proceeding to enforce the provisions of P.L.1981, c.142 (C.52:13D-17.2 et al.),
P.L.2009, c.307 (C.24:6I-1 et al.), P.L.2021, c.16 (C.24:6I-31 et al.), or the
regulations of the Cannabis Regulatory Commission.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      h.   Any
person who willfully violates the provisions of this section is a disorderly
person and shall be subject to a fine not to exceed $1,000, or imprisonment not
to exceed six months, or both.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>      In
addition, for violations of subsection c. of this section occurring after the
effective date of P.L.2005, c.382, a civil penalty of not less than $500 nor
more than $10,000 shall be imposed upon a former State officer or employee or
former special State officer or employee of a State agency in the Executive
Branch upon a finding of a violation by the State Ethics Commission, which
penalty may be collected in a summary proceeding pursuant to the &quot;Penalty
Enforcement Law of 1999,&quot; P.L.1999, c.274 (C.2A:58-10 et seq.).</span><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>2</span></sup></b></p>

<p class=MsoNormal style='line-height:150%'><span style='letter-spacing:0pt'>(cf:
P.L.2023, c.291, s.1)</span></p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     <b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>2.<b><span
style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b><span
style='font-family:"Albertus Extra Bold",sans-serif'>  </span><u>3.</u><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b>   This
act shall take effect immediately. </p>

</div>

</body>

</html>
